⌘K
Loading ticker…
As of 2026-08-25, AngioDynamics, Inc. (ANGO) has a 3-month relative strength percentile of 90 and a leadership percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.0%, relative volume 0.63×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ANGO is held by 19 ETFs as of May 2026. Top owner: SCHA at 0.01% weight, $2M notional. Top 3 carry $6M.
Held by 41 ETFs · $57M across latest filings · largest weight 0.78% (XHE).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| VTWO | 0.01% | $2M | — |
| VHTVanguard Health Care ETF | 0.01% | $1M | — |
| AVSC | 0.04% | $1M | — |
| GSSC | 0.07% | $661K | −0.02 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.09% |
| $576K |
| −0.01 pp |
| VTWV | 0.02% | $269K | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $264K | — |
| VFQY | 0.02% | $105K | new |
| VTWG | 0.01% | $88K | — |
Showing 10 of 19 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ANGO Jan avg: -6.24% median: -12.38% win: 25% σ: 22.08% n: 4 2022-04-12 → 2026-07-31 | ANGO Feb avg: -5.00% median: -5.93% win: 25% σ: 11.92% n: 4 2022-04-12 → 2026-07-31 | ANGO Mar avg: -2.27% median: 0.23% win: 50% σ: 10.01% n: 4 2022-04-12 → 2026-07-31 | ANGO Apr avg: -6.45% median: -3.78% win: 0% σ: 7.64% n: 5 2022-04-12 → 2026-07-31 | ANGO May avg: 6.13% median: 8.98% win: 80% σ: 7.84% n: 5 2022-04-12 → 2026-07-31 | ANGO Jun avg: 3.06% median: -1.43% win: 40% σ: 8.10% n: 5 2022-04-12 → 2026-07-31 | ANGO Jul avg: 6.63% median: 13.68% win: 60% σ: 19.58% n: 5 2022-04-12 → 2026-07-31 | ANGO Aug avg: 0.23% median: -3.64% win: 25% σ: 10.59% n: 4 2022-04-12 → 2026-07-31 (current) | ANGO Sep avg: -0.85% median: -1.65% win: 50% σ: 8.80% n: 4 2022-04-12 → 2026-07-31 | ANGO Oct avg: -13.16% median: -14.60% win: 25% σ: 15.95% n: 4 2022-04-12 → 2026-07-31 | ANGO Nov avg: 0.97% median: 3.33% win: 75% σ: 6.12% n: 4 2022-04-12 → 2026-07-31 | ANGO Dec avg: 15.53% median: 13.20% win: 100% σ: 13.24% n: 4 2022-04-12 → 2026-07-31 |